Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
5
×
new york top stories
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
clinical trials
national top stories
deals
europe blog main
europe top stories
national
startups
abbvie
alzheimer's disease
amgen
biotech ipos
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chronic kidney disease
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
investing
medical device
merck
moderna
pfizer
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
What
week
5
×
companies
life
science
street
wall
bio
biotech
ceo
debut
drug
ipo
moves
roundup
way
welcomed
aces
acquisitions
announced
arrival
big
biggest
black
boost
build
buy
cholesterol
company’s
continue
daniel
days
diamond
diamond’s
dyne’s
flexible
followed
genomics
gilead
hasn’t
haul
Language
unset
5
×
Current search:
week
×
unset
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing